Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Begin-Period-Cashflow" stands at 1.11 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2024.
Eisai Co. Ltd.'s second quarter result of 0.2854 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 7.46 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 0.2854 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -6.10 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 1.11 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -1.64 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.45 percent compared to the value the year prior.
The 1 year change in percent is -5.45.
The 3 year change in percent is -2.46.
The 5 year change in percent is 22.27.
The 10 year change in percent is 77.19.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Begin Period Cashflow | 905,699,262,464.00 |
![]() | Johnson & Johnson - Begin Period Cashflow | 486,508,953,600.00 |
![]() | AbbVie Inc - Begin Period Cashflow | 399,570,305,024.00 |
![]() | Roche Holding AG - Begin Period Cashflow | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Begin Period Cashflow | 280,205,508,085.11 |